Phase III Trial Opens: Digital Symptom Monitoring App vs Standard Care in Cancer — What Clinicians Need to Know

References

1. 1.Absolom, K., Warrington, L., Hudson, E., Hewison, J., Morris, C., Holch, P., Carter, R., Gibson, A., Hinsley, S., Velikova, G., & eRAPID Trial Management Group. (2021). Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. Journal of Clinical Oncology, 39(7), 734-747. https://doi.org/10.1200/JCO.20.02015
2. 2.Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197-198. https://doi.org/10.1001/jama.2017.7156
3. 3.Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Balk, E. M., Rogak, L., Cycowitz, K., Zipkin, D., & Schrag, D. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. Journal of Clinical Oncology, 34(6), 557-565. https://doi.org/10.1200/JCO.2015.63.0830
4. 4.Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. C., & Letellier, C. (2019). Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA, 321(3), 306-307. https://doi.org/10.1001/jama.2018.18085
5. 5.Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Di Domenico, D., Croy, S., & MacGillivray, S. (2014). What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? Journal of Clinical Oncology, 32(14), 1480-1501. https://doi.org/10.1200/JCO.2013.53.5948
6. 6.Resilience. (2024). Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102). ClinicalTrials.gov. NCT06867705. https://clinicaltrials.gov/study/NCT06867705
7. 7.Ruland, C. M., Holte, H. H., Røislien, J., Heaven, C., Hamilton, G. A., Kristiansen, J., Sandbaek, H., Kvaløy, S. O., Hasund, M., Ellison, M. C., & Andersen, T. (2010). Effects of a computer-supported system to monitor symptoms and communicate with healthcare providers on quality of life in cancer patients. Journal of the American Medical Informatics Association, 17(2), 161-168. https://doi.org/10.1136/jamia.2009.002022
8. 8.Sedhom, R., Gupta, A., Kopetz, S., Jabbour, S. K., Malin, J. L., & Manne, S. (2022). Mobile health applications in oncology: a systematic review of health care interventions and outcomes. JMIR mHealth and uHealth, 10(3), e35543. https://doi.org/10.2196/35543